Lauren Detjen
Family · Kenilworth, ILNPI 1447899620
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,393, 4.0 times the $344 reported in 2021. Among family clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $22.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Regeneron Healthcare Solutions, Inc.$743
- Sanofi$672
- GSK$468
- Kaleo, Inc.$274
- Genentech USA, Inc.$253
- plus $1K from 20 others
What the payments were for
- Food & beverage$4,74098%
- Education$1072%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 51 | $1,031 |
| Regeneron Healthcare Solutions, Inc. | 31 | $743 |
| Sanofi | 27 | $672 |
| GSK | 22 | $468 |
| Kaleo, Inc. | 12 | $274 |
| Genentech USA, Inc. | 10 | $253 |
| Novartis | 13 | $165 |
| Pharming Healthcare, Inc. | 5 | $124 |
| Hikma Pharmaceuticals USA | 6 | $121 |
| Pfizer | 5 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Blueprint Medicines Corporation | 4 | $102 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $81 |
| AbbVie | 3 | $69 |
| Biocryst US Sales Co., LLC | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Phadia US Inc. | 3 | $51 |
| Alk-abello, Inc | 2 | $46 |
| Boehringer Ingelheim | 2 | $43 |
| Galderma Laboratories, L.p. | 2 | $35 |
| Cycle Pharmaceuticals Inc | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Optinose US, Inc. | 1 | $22 |
| Amgen | 1 | $22 |
| Merck | 1 | $20 |
How this compares
$4,846 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,528 |
| Montelukast Sodium | 20 | $423 |
| Ipratropium Bromide | 12 | $334 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $320 |
Paid to pharmacies, not to this prescriber.
Other family in Kenilworth
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.